Evidence map›Paper›PMID 38904858›Full record

ReviewWorld journal of microbiology & biotechnology2024

Mechanisms and high-value applications of phthalate isomers degradation pathways in bacteria.

Qiu Lequan, Fu Yanan, Zhou Xianda, Bao Mengyuan, Li Chenyu, Wu Shijin

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiu LequanCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China. lqqiu@zjut.edu.cn.
Fu YananCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
Zhou XiandaCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
Bao MengyuanCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
Li ChenyuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
Wu ShijinCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China. wujan28@zjut.edu.cn.

Funding

Natural Science Foundation of Zhejiang Province No. LGF22E060004
6 · The paper itself

Abstract

Phthalate isomers are key intermediates in the biodegradation of pollutants including waste polyethylene terephthalate (PET) plastics and plasticizers. So far, an increasing number of phthalate isomer-degrading strains have been isolated, and their degradation pathways show significant diversity. In this paper, we comprehensively review the current status of research on the degrading bacteria, degradation characteristics, aerobic and anaerobic degradation pathways, and degradation genes (clusters) of phthalate isomers, and discuss the current shortcomings and challenges. Moreover, the degradation process of phthalate isomers produces many important aromatic precursor molecules, which can be used to produce higher-value derivative chemicals, and the modification of their degradation pathways holds good prospects. Therefore, this review also highlights the current progress made in modifying the phthalate isomer degradation pathway and explores its potential for high-value applications.

Indexed as

BacteriaBiodegradation, EnvironmentalPhthalic AcidsEnvironmental PollutantsIsomerismMetabolic Networks and PathwaysPlasticizersPolyethylene TerephthalatesEnvironmental Pollutantsphthalic acidPhthalic AcidsPlasticizersPolyethylene TerephthalatesAerobic degradationAnaerobic degradationPhthalate isomersPhthalic acid esters, high-value applicationWaste PET

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.